Impact of biological therapy on body composition of patients with Chron's disease

Detalhes bibliográficos
Autor(a) principal: Santos,Julianne Campos dos
Data de Publicação: 2017
Outros Autores: Malaguti,Carla, Lucca,Fernando de Azevedo, Cabalzar,Andrea Lemos, Ribeiro,Tarsila Campanha da Rocha, Gaburri,Pedro Duarte, Chebli,Liliana Andrade, Chebli,Julio Maria Fonseca
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Associação Médica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000500407
Resumo: Summary Introduction: Protein-energy malnutrition in Crohn's disease (CD) has been reported in 20 to 92% of patients, and is associated with increased morbidity and mortality and higher costs for the health system. Anti-TNF drugs are a landmark in the clinical management, promoting prolonged remission in patients with CD. It is believed that the remission of this disease leads to nutritional recovery. The effect of biological therapy on body composition and nutritional status is unclear. Method: Prospective study of body assessment by bioelectrical impedance method in patients with moderate to severe CD undergoing treatment with infliximab. The main outcome was the body composition before and after 6 months of anti-TNF therapy. Results: There was a predominance of females (52%) with a mean age of 42±12 years. Most patients were eutrophic at baseline and remained so. There was an increase in all parameters of body composition after anti-TNF treatment: BMI (22.9±3.2 versus 25±3.8; p=0.005), waist circumference (88.1±6.7 versus 93.9±7.7; p=0.002), lean mass index (17.5±2.2 versus 18.2±2.3; p=0.000) and fat mass index (5.5±2.3 versus 6.8±2.3; p=0.000). Phase angle remained unchanged (6.2 versus 6.8; p=0.94). Conclusion: After therapy with IFX, all components of body composition increased, except for phase angle. The substantial increase in fat mass index and waist circumference led to concern regarding cardiovascular risk and, thus, to the need for further studies.
id AMB-1_85c4f2bf2f26788903cf375187c7a7a7
oai_identifier_str oai:scielo:S0104-42302017000500407
network_acronym_str AMB-1
network_name_str Revista da Associação Médica Brasileira (Online)
repository_id_str
spelling Impact of biological therapy on body composition of patients with Chron's diseaseCrohn's diseasebody compositionbiologicsSummary Introduction: Protein-energy malnutrition in Crohn's disease (CD) has been reported in 20 to 92% of patients, and is associated with increased morbidity and mortality and higher costs for the health system. Anti-TNF drugs are a landmark in the clinical management, promoting prolonged remission in patients with CD. It is believed that the remission of this disease leads to nutritional recovery. The effect of biological therapy on body composition and nutritional status is unclear. Method: Prospective study of body assessment by bioelectrical impedance method in patients with moderate to severe CD undergoing treatment with infliximab. The main outcome was the body composition before and after 6 months of anti-TNF therapy. Results: There was a predominance of females (52%) with a mean age of 42±12 years. Most patients were eutrophic at baseline and remained so. There was an increase in all parameters of body composition after anti-TNF treatment: BMI (22.9±3.2 versus 25±3.8; p=0.005), waist circumference (88.1±6.7 versus 93.9±7.7; p=0.002), lean mass index (17.5±2.2 versus 18.2±2.3; p=0.000) and fat mass index (5.5±2.3 versus 6.8±2.3; p=0.000). Phase angle remained unchanged (6.2 versus 6.8; p=0.94). Conclusion: After therapy with IFX, all components of body composition increased, except for phase angle. The substantial increase in fat mass index and waist circumference led to concern regarding cardiovascular risk and, thus, to the need for further studies.Associação Médica Brasileira2017-05-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000500407Revista da Associação Médica Brasileira v.63 n.5 2017reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.63.05.407info:eu-repo/semantics/openAccessSantos,Julianne Campos dosMalaguti,CarlaLucca,Fernando de AzevedoCabalzar,Andrea LemosRibeiro,Tarsila Campanha da RochaGaburri,Pedro DuarteChebli,Liliana AndradeChebli,Julio Maria Fonsecaeng2017-07-10T00:00:00Zoai:scielo:S0104-42302017000500407Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2017-07-10T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false
dc.title.none.fl_str_mv Impact of biological therapy on body composition of patients with Chron's disease
title Impact of biological therapy on body composition of patients with Chron's disease
spellingShingle Impact of biological therapy on body composition of patients with Chron's disease
Santos,Julianne Campos dos
Crohn's disease
body composition
biologics
title_short Impact of biological therapy on body composition of patients with Chron's disease
title_full Impact of biological therapy on body composition of patients with Chron's disease
title_fullStr Impact of biological therapy on body composition of patients with Chron's disease
title_full_unstemmed Impact of biological therapy on body composition of patients with Chron's disease
title_sort Impact of biological therapy on body composition of patients with Chron's disease
author Santos,Julianne Campos dos
author_facet Santos,Julianne Campos dos
Malaguti,Carla
Lucca,Fernando de Azevedo
Cabalzar,Andrea Lemos
Ribeiro,Tarsila Campanha da Rocha
Gaburri,Pedro Duarte
Chebli,Liliana Andrade
Chebli,Julio Maria Fonseca
author_role author
author2 Malaguti,Carla
Lucca,Fernando de Azevedo
Cabalzar,Andrea Lemos
Ribeiro,Tarsila Campanha da Rocha
Gaburri,Pedro Duarte
Chebli,Liliana Andrade
Chebli,Julio Maria Fonseca
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Santos,Julianne Campos dos
Malaguti,Carla
Lucca,Fernando de Azevedo
Cabalzar,Andrea Lemos
Ribeiro,Tarsila Campanha da Rocha
Gaburri,Pedro Duarte
Chebli,Liliana Andrade
Chebli,Julio Maria Fonseca
dc.subject.por.fl_str_mv Crohn's disease
body composition
biologics
topic Crohn's disease
body composition
biologics
description Summary Introduction: Protein-energy malnutrition in Crohn's disease (CD) has been reported in 20 to 92% of patients, and is associated with increased morbidity and mortality and higher costs for the health system. Anti-TNF drugs are a landmark in the clinical management, promoting prolonged remission in patients with CD. It is believed that the remission of this disease leads to nutritional recovery. The effect of biological therapy on body composition and nutritional status is unclear. Method: Prospective study of body assessment by bioelectrical impedance method in patients with moderate to severe CD undergoing treatment with infliximab. The main outcome was the body composition before and after 6 months of anti-TNF therapy. Results: There was a predominance of females (52%) with a mean age of 42±12 years. Most patients were eutrophic at baseline and remained so. There was an increase in all parameters of body composition after anti-TNF treatment: BMI (22.9±3.2 versus 25±3.8; p=0.005), waist circumference (88.1±6.7 versus 93.9±7.7; p=0.002), lean mass index (17.5±2.2 versus 18.2±2.3; p=0.000) and fat mass index (5.5±2.3 versus 6.8±2.3; p=0.000). Phase angle remained unchanged (6.2 versus 6.8; p=0.94). Conclusion: After therapy with IFX, all components of body composition increased, except for phase angle. The substantial increase in fat mass index and waist circumference led to concern regarding cardiovascular risk and, thus, to the need for further studies.
publishDate 2017
dc.date.none.fl_str_mv 2017-05-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000500407
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000500407
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1806-9282.63.05.407
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Médica Brasileira
publisher.none.fl_str_mv Associação Médica Brasileira
dc.source.none.fl_str_mv Revista da Associação Médica Brasileira v.63 n.5 2017
reponame:Revista da Associação Médica Brasileira (Online)
instname:Associação Médica Brasileira (AMB)
instacron:AMB
instname_str Associação Médica Brasileira (AMB)
instacron_str AMB
institution AMB
reponame_str Revista da Associação Médica Brasileira (Online)
collection Revista da Associação Médica Brasileira (Online)
repository.name.fl_str_mv Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)
repository.mail.fl_str_mv ||ramb@amb.org.br
_version_ 1754212832479543296